Use descriptive words that you would associate strongly with the content of your paper: the molecule studied, the organism used or studied, the treatment, the location of a field site, the response measured, etc.
In our study, HER2 overexpression or HER2 amplification had to be confirmed by a central laboratory before randomization, thereby reducing the risk of false positive results. It is our view that adjuvant trastuzumab should be considered only if the HER2-positive status of the tumor has been determined by a high-volume laboratory with quality-control procedures.
Feng Du, Peng Yuan, Wenjie Zhu, Jiayu Wang, Fei Ma, Ying Fan, Binghe Xu. . (2014) Is it safe to give anthracyclines concurrently with trastuzumab in neo-adjuvant or metastatic settings for HER2-positive breast cancer? A meta-analysis of randomized controlled trials. 31.
Manfred Kaufmann, Gunter Minckwitz, Jonas Bergh, Pier-Franco Conte, Sarah Darby, Wolfgang Eiermann, Antony Howell, Marion Kiechle, Davide Mauri, Hans-Jörg Senn, Giuseppe Viale, Sibylle Loibl. . (2013) Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades. 288, 1203-1212.
Inna Y. Gong, Sunil Verma, Andrew T. Yan, Dennis T. Ko, Craig C. Earle, George A. Tomlinson, Maureen E. Trudeau, Murray D. Krahn, Monika K. Krzyzanowska, Christine B. Brezden-Masley, Scott Gavura, Stuart Peacock, Kelvin K. W. Chan. . (2016) Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study. 157:3, 535-544.